Clinicopathological findings of a long-term survivor of V180I genetic Creutzfeldt-Jakob disease.
Yuichi HayashiYasushi IwasakiMasahiro WazaShinei KatoAkio AkagiAkio KimuraTakashi InuzukaKatsuya SatohTetsuyuki KitamotoMari YoshidaTakayoshi ShimohataPublished in: Prion (2021)
The clinical characteristics of genetic Creutzfeldt-Jakob disease (gCJD) with a V180I mutation in the PRNP gene (V180I gCJD) are unique: elderly-onset, gradual progression, sporadic fashion, and cortical oedematous hyper-intensity on diffusion-weighted MRI (DW-MRI). This phenotype may become a potential target of future clinical therapeutic trials. The average disease duration of V180I gCJD patients is 23-27 months; however, considerably long-term survivors are also reported. The factors influencing survival and the clinicopathological characteristics of long-term survivors remain unknown. Herein, we report clinicopathological findings of a long-term survivor of V180I gCJD. A 78-year old woman was admitted to our hospital due to dementia and left hand tremor approximately 1.5 months after symptom onset. Neurological examination revealed dementia, frontal signs, and left hand tremor at admission. She had no family history of dementia or other neurological disease. DW-MRI revealed cortical oedematous hyper-intensities in the bilateral frontal lobes and the right temporal and parietal lobes. PRNP gene analysis indicated a V180I mutation with methionine homozygosity at codon 129. The symptoms gradually progressed, and she died of aspiration pneumonia 61 months after symptom onset. Neuropathological examination revealed severe cerebral atrophy with moderate to severe gliosis, but the brainstem was well preserved. Various-sized and non-confluent vacuole type spongiform changes were extensively observed in the cerebral cortices. Prion protein (PrP) immunostaining revealed weak and synaptic-type PrP deposits in the cerebral cortices. We consider that long-term tube feeding, and very mild brainstem involvement may be associated with the long-term survival of our V180I gCJD patient.
Keyphrases
- contrast enhanced
- diffusion weighted
- mild cognitive impairment
- magnetic resonance imaging
- genome wide
- single cell
- subarachnoid hemorrhage
- emergency department
- copy number
- working memory
- end stage renal disease
- cerebral ischemia
- newly diagnosed
- early onset
- case report
- magnetic resonance
- diffusion weighted imaging
- multidrug resistant
- brain injury
- physical activity
- depressive symptoms
- dna methylation
- chronic kidney disease
- high intensity
- climate change
- small molecule
- blood brain barrier
- patient reported outcomes
- genome wide identification
- adverse drug